Rosmarinic acid inhibits 6-OHDA-induced neurotoxicity by anti-oxidation in MES23.5 cells

Journal of Molecular Neuroscience

Volumn 39, Issue 1-2, 2009, Pages 220-225

  Ren, Pei ^a   Jiang, Hong ^a   Li, Ronggui ^a   Wang, Jun ^a   Song, Ning ^a   Xu, Hua Min ^a   Xie, Jun Xia ^a  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

6 OHDA; Anti oxidation; MES23.5 cell; Parkinson's disease; Rosmarinic acid

Indexed keywords

OXIDOPAMINE; REACTIVE OXYGEN METABOLITE; ROSMARINIC ACID;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROTECTION; CELL VIABILITY; DRUG MECHANISM; MITOCHONDRIAL MEMBRANE POTENTIAL; NEUROTOXICITY; PARKINSON DISEASE;

ADRENERGIC AGENTS; ANIMALS; ANTIOXIDANTS; CELL LINE; CINNAMATES; DEPSIDES; HUMANS; LAMIACEAE; MICE; NEUROTOXICITY SYNDROMES; OXIDOPAMINE; RATS; REACTIVE OXYGEN SPECIES;

LAMIACEAE; PERILLA FRUTESCENS; RATTUS;

EID: 74149086090     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-009-9182-y     Document Type: Article

References (35)

1. Andersen, J. K. (2004). Iron dysregulation and Parkinson's disease. Journal of Alzheimer's Disease, 6 (6, Suppl), S47-S52.
2. Blum, D., Torch, S., Lambeng, N., et al. (2001). Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Progress in Neurobiology, 65 (2), 135-172. doi:10.1016/S0301-0082 (01) 00003-X.
3. Breese, G. R., & Traylor, T. D. (1970). Effect of 6-hydroxydopamine on brain norepinephrine and dopamine evidence for selective degeneration of catecholamine neurons. The Journal of Pharmacology and Experimental Therapeutics, 174 (3), 413-420.
4. Chen, S. Z., Fu, Y. P., & Wu, R. S. (1999). Effects of rosmarinic acid on free radical production and lysosomal enzyme release from rat peritoneal neutrophils. Acta Pharmacologica Sinica, 34, 881-885.
5. Chen, Y., & Chen, X. C. (2002). Possible mechanisms of the protective effect of ginsenoside Rg1 on apoptosis in substantia nigra neurons. Yao Xue Xue Bao, 37 (4), 249-252.
6. Chen, X. C., Zhou, Y. C., Chen, Y., Zhu, Y. G., Fang, F., & Chen, L. M. (2005). Ginsenoside Rg1 reduces MPTP-induced substantia nigra neuron loss by suppressing oxidative stress. Acta Pharmacologica Sinica, 26 (1), 56-62. doi:10.1111/j.1745-7254.2005.00019.x.
7. Chlopcíková, S., Psotová, J., Miketová, P., Sousek, J., Lichnovský, V., & Simánek, V. (2004). Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes. Part II. Caffeic, chlorogenic and rosmarinic acids. Phytotherapy Research, 18 (5), 408-413. doi:10.1002/ptr.1461.
8. Choi, J. Y., Park, C. S., Kim, D. J., Cho, M. H., Jin, B. K., Pie, J. E., & Chung, W. G. (2002). Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced Parkinson's disease in mice by tea phenolic epigallocatechin 3-gallate. Neurotoxicology, 23 (3), 367-374. doi:10.1016/S0161-813X (02) 00079-7.
9. Crawford Jr, G. D., Le, W. D., Smith, R. G., Xie, W. J., Stefani, E., & Appel, S. H. (1992). A novel N18TG2 X mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin. The Journal of Neuroscience, 12 (9), 3392-3398.
10. Gandhi, S., & Wood, N. W. (2005). Molecular pathogenesis of Parkinson's disease. Human Molecular Genetics, 14, 2749-2755. doi:10.1093/hmg/ddi308.
11. Gerlach, M., & Riederer, P. (1996). Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man. Journal of Neural Transmission, 103 (8-9), 987-1041. doi:10.1007/ BF01291788.
12. Glinka, Y., Gassen, M., & Youdim, M. B. (1997). Mechanism of 6-hydroxydopamine neurotoxicity. Journal of Neural Transmission. Supplementum, 50, 55-66.
13. Iuvone, T., De Filippis, D., Esposito, G., D'Amico, A., & Izzo, A. A. (2006). The spice sage and its active ingredient rosmarinic acid protect PC12 cells from amyloid-beta peptide-induced neurotoxicity. The Journal of Pharmacology and Experimental Therapeutics, 317 (3), 1143-1149. doi:10.1124/jpet.105.099317.
14. Jenner, P. (2003). Oxidative stress in Parkinson's disease. Annals of Neurology, 53 (Suppl 13), S26-S36 discussion S36-38 doi: 10.1002/ana.10483.
15. Jenner, P., & Olanow, C. W. (1996). Oxidative stress and the pathogenesis of Parkinson's disease. Neurology, 47 (6, Suppl 13), S161-S170.
16. Karoum, F., Chrapusta, S. J., Egan, M. F., & Wyatt, R. J. (1993). Absence of 6-hydroxydopamine in the rat brain after treatment with stimulants and other dopaminergic agents: a mass fragmentographic study. Journal of Neurochemistry, 61 (4), 1369-1375. doi:10.1111/j.1471-4159.1993.tb13630.x.
17. Kidd, P. M. (2000). Parkinson's disease as multifactorial oxidative neurodegeneration: implications for integrative management. Alternative Medicine Review, 5 (6), 502-529.
18. Kikuchi, A., Takeda, A., Onodera, H., et al. (2002). Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy. Neurobiology of Disease, 9 (2), 244-248. doi:10.1006/nbdi.2002. 0466.
19. Levites, Y., Amit, T., Youdim, M. B., & Mandel, S. (2002). Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action. The Journal of Biological Chemistry, 277 (34), 30574-30580. doi:10.1074/jbc. M202832200.
20. Li, R., Peng, N., Du, F., Li, X. P., & Le, W. D. (2006). Epigallocatechin gallate protects dopaminergic neurons against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced neurotoxicity by inhibiting microglial cell activation. Nan Fang Yi Ke Da Xue Xue Bao, 26 (4), 376-380.
21. Lotharius, J., & Brundin, P. (2002). Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. Nature Reviews. Neuroscience, 3 (12), 932-942. doi:10.1038/nrn983.
22. Ono, K., & Yamada, M. (2006). Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro. Journal of Neurochemistry, 97 (1), 105-115. doi:10.1111/j.1471-4159.2006.03707.x.
23. Onyango, I. G. (2008). Mitochondrial dysfunction and oxidative stress in Parkinson's disease. Neurochemical Research, 33 (3), 589-597. doi:10.1007/s11064-007-9482-y.
24. Petersen, M., & Simmonds, M. S. (2003). Rosmarinic acid. Phytochemistry, 62 (2), 121-125. doi:10.1016/S0031-9422 (02) 00513-7.
25. Przedborski, S. (2005). Pathogenesis of nigral cell death in Parkinson's disease. Parkinsonism & Related Disorders, 11 (Suppl 1), S3-S7. doi:10.1016/j.parkreldis.2004.10.012.
26. Sanelli, T., Ge, W., Leystra-Lantz, C., & Strong, M. J. (2007). Calcium mediated excitotoxicity in neurofilament aggregatebearing neurons in vitro is NMDA receptor dependant. Journal of the Neurological Sciences, 256 (1-2), 39-51. doi:10.1016/j. jns.2007.02.018.
27. Sayre, L. M., Perry, G., & Smith, M. A. (2008). Oxidative stress and neurotoxicity. Chemical Research in Toxicology, 21 (1), 172-188. doi:10.1021/tx700210j.
28. Schapira, A. H. (1997). Pathogenesis of Parkinson's disease. Bailliere's Clinical Neurology, 6, 15-36.
29. Schulz, J. B., & Falkenburger, B. H. (2004). Neuronal pathology in Parkinson's disease. Cell and Tissue Research, 318, 135-147. doi:10.1007/s00441-004-0954-y.
30. Sherer, T. B., Betarbet, R., & Greenamyre, J. T. (2001). Pathogenesis of Parkinson's disease. Current Opinion in Investigational Drugs (London, England), 2, 657-662.
31. Shibata, N., & Kobayashi, M. (2008). The role for oxidative stress in neurodegenerative diseases. Brain Nerve, 60 (2), 157-170.
32. Soto-Otero, R., Méndez-Alvarez, E., Hermida-Ameijeiras, A., Muñoz-Patiño, A. M., & Labandeira-Garcia, J. L. (2000). Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson's disease. Journal of Neurochemistry, 74 (4), 1605-1612. doi:10.1046/j.1471-4159.2000.0741605.x.
33. Thomas, B., & Beal, M. F. (2007). Parkinson's disease. Human Molecular Genetics, 16 (Spec No. 2), R183-R194.
34. Zhang, S., Wang, J., Song, N., Xie, J., & Jiang, H. (2008). Upregulation of divalent metal transporter 1 is involved in 1-methyl-4- phenylpyridinium (MPP (+))-induced apoptosis in MES23.5 cells. Neurobiology of Aging, in press.
35. Zhu, H. J., & Liu, G. Q. (2004). Glutamate up-regulates P-glycoprotein expression in rat brain microvessel endothelial cells by an NMDA receptor-mediated mechanism. Life Sciences, 75 (11), 1313-1322.